Found: 9
Select item for more details and to access through your institution.
Epigallocatechin-3-gallate Enhances the Efficacy of MicroRNA-34a Mimic and MiR-93 Inhibitor Co-transfection in Prostate Cancer Cell Line.
- Published in:
- Iranian Journal of Allergy, Asthma & Immunology, 2020, v. 19, n. 6, p. 612
- By:
- Publication type:
- Article
SDF-1α Reduces Human Natural Killer Cell Cytotoxicity against Chronic Myelogenous Leukemia K562 Cells.
- Published in:
- Iranian Journal of Allergy, Asthma & Immunology, 2019, v. 18, n. 5, p. 493
- By:
- Publication type:
- Article
Urinary MicroRNAs, Possible Biomarkers for Early Detection of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Published in:
- Iranian Journal of Kidney Diseases, 2023, v. 17, n. 2, p. 73, doi. 10.52547/ijkd.7281
- By:
- Publication type:
- Article
Dialysis-Induced Immune Dysregulations and Their Possible Impacts on COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- journal article
PD‐L1 overexpression conveys tolerance of mesenchymal stem cell‐derived cardiomyocyte‐like cells in an allogeneic mouse model.
- Published in:
- Journal of Cellular Physiology, 2021, v. 236, n. 9, p. 6328, doi. 10.1002/jcp.30299
- By:
- Publication type:
- Article
An update on potentials and promises of T cell co‐signaling molecules in transplantation.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 5, p. 4183, doi. 10.1002/jcp.29369
- By:
- Publication type:
- Article
CTLA4-Ig alleviates the allogeneic immune responses against insulin-producing cells in a murine model of cell transplantation.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, v. 396, n. 11, p. 3195, doi. 10.1007/s00210-023-02527-0
- By:
- Publication type:
- Article
Zoledronic acid-loaded lipidic nanoparticles enhance apoptosis and attenuate invasiveness by inhibiting epithelial to mesenchymal transition (EMT) in HepG<sub>2</sub> cancer cells.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, v. 394, n. 12, p. 2429, doi. 10.1007/s00210-021-02164-5
- By:
- Publication type:
- Article
Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model.
- Published in:
- Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, v. 394, n. 11, p. 2309, doi. 10.1007/s00210-021-02134-x
- By:
- Publication type:
- Article